Title:
VACCINE FOR PREVENTING OR TREATING CORONAVIRUS INFECTION OR SYMPTOMS ASSOCIATED WITH CORONAVIRUS INFECTION
Document Type and Number:
WIPO Patent Application WO/2021/200800
Kind Code:
A1
Abstract:
The present invention provides a vaccine to be used for preventing or treating coronavirus infection and symptoms associated with coronavirus infection.
More Like This:
| WO/2015/143335 | METHODS AND COMPOSITIONS FOR CHIMERIC CORONAVIRUS SPIKE PROTEINS |
| JP2009112301 | MUTANT FORM OF CHOLERA HOLOTOXIN AS ADJUVANT |
| WO/2022/241760 | SAFER VACCINES |
Inventors:
NAKAGAMI HIRONORI (JP)
MORISHITA RYUICHI (JP)
HAYASHI HIROKI (JP)
KOMATSUNO TAKAO (JP)
MORISHITA RYUICHI (JP)
HAYASHI HIROKI (JP)
KOMATSUNO TAKAO (JP)
Application Number:
PCT/JP2021/013237
Publication Date:
October 07, 2021
Filing Date:
March 29, 2021
Export Citation:
Assignee:
UNIV OSAKA (JP)
ANGES INC (JP)
ANGES INC (JP)
International Classes:
A61K39/215; A61K39/39; A61P31/14; C07K14/165; C12N15/50; C12N15/63
Domestic Patent References:
| WO2006009011A1 | 2006-01-26 |
Foreign References:
| JP2006101840A | 2006-04-20 | |||
| JP2012510449A | 2012-05-10 |
Other References:
DATABASE Nucleotide 13 March 2020 (2020-03-13), ANONYMOUS : "Severe acute respiratory syndrome coronavirus 2 isolate Wuhan-Hu-1, complete genome", XP055886368, Database accession no. NC_045512
RICHMOND, P. ET AL.: "Safety and immunogenicity of S-Trimer(SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial", LANCET, vol. 397, 20 February 2021 (2021-02-20), pages 682 - 694, XP055914260
ARASHKIA ET AL.: "Severe acute respiratory syndrome‐coronavirus‐2 spike (S) protein based vaccine candidates: State of the art and future prospects", REVIEWS IN MEDICAL VIROLOGY, vol. 31, no. 3, 1 May 2021 (2021-05-01), GB , XP055926123, ISSN: 1052-9276, DOI: 10.1002/rmv.2183
RICHMOND, P. ET AL.: "Safety and immunogenicity of S-Trimer(SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial", LANCET, vol. 397, 20 February 2021 (2021-02-20), pages 682 - 694, XP055914260
ARASHKIA ET AL.: "Severe acute respiratory syndrome‐coronavirus‐2 spike (S) protein based vaccine candidates: State of the art and future prospects", REVIEWS IN MEDICAL VIROLOGY, vol. 31, no. 3, 1 May 2021 (2021-05-01), GB , XP055926123, ISSN: 1052-9276, DOI: 10.1002/rmv.2183
Attorney, Agent or Firm:
TAKASHIMA, Hajime (JP)
Download PDF: